Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment
about
Psychological and pharmacological interventions for depression in patients with coronary artery diseaseInfluence of antidepressants on hemostasisDepression and the Link with Cardiovascular DiseaseAntidepressants and cardiovascular adverse events: A narrative reviewPlatelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes.Treating depression in patients with chronic disease: recognition and treatment are crucial; depression worsens the course of a chronic illness.Treatment of depression in comorbid medical illness.Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients.Excess risk of chronic physical conditions associated with depression and anxietySafety of antidepressant drugs in the patient with cardiac disease: a review of the literature.Broken heart: depression in cardiovascular disease.Responses of mental stress-induced myocardial ischemia to escitalopram treatment: background, design, and method for the Responses of Mental Stress Induced Myocardial Ischemia to Escitalopram Treatment trial.Pharmacologic treatment of depression in patients with myocardial infarctionNegative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, and future directions.Depression and disability in people with podoconiosis: a comparative cross-sectional study in rural Northern Ethiopia.Aging and clinical pharmacology: implications for antidepressants.Depression and coronary heart diseaseEffect of age, weight, and CYP2C19 genotype on escitalopram exposure.Effect of selective serotonin reuptake inhibitors on cardiovascular morbidity and mortality.Platelets and depression in cardiovascular disease: A brief review of the current literatureInfluence of mental stress on platelet bioactivity.Citalopram intervention for hostility: results of a randomized clinical trial.Platelet function in patients with major depression.Persistent versus transient depressive symptoms in relation to platelet hyperactivation: a longitudinal analysis of dementia caregivers.Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression.Depression and the cardiovascular system: increasing evidence of a link and therapeutic implications.Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome?Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry.Depression and cardiovascular disease: a clinical review.The interface of depression and cardiovascular disease: therapeutic implications.The use of selective serotonin receptor inhibitors (SSRIs) is not associated with increased risk of endoscopy-refractory bleeding, rebleeding or mortality in peptic ulcer bleeding.Sound mind vs sound heart.Selective Serotonin Reuptake Inhibitors and Operative Bleeding Risk: A Review of the Literature.Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice.Possible Role of Platelet GluR1 Receptors in Comorbid Depression and Cardiovascular Disease.Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis.[Depression. An underestimated risk for the development and progression of coronary heart disease].Coagulation activation and fibrinolysis impairment are reduced in patients with anxiety and depression when medicated with serotonergic antidepressants.Sertraline treatment for depression associated with acute coronary syndromes: a cost analysis from the viewpoint of the Italian Healthcare System.
P2860
Q24234331-9BE8AB16-E4F6-41BE-BECC-3ABEC9C6B9BDQ24635625-7C090AA3-D967-45A7-A498-CCCBAB11FF7FQ26752379-C82BF05A-7988-476F-A84C-9423D901E329Q26771629-01D16A5C-8773-4B5B-A0CC-C8AD20817C23Q31102771-C67BAE46-43EA-443D-BC7B-B1BA3EC3FFFAQ33868089-8F3D3BA8-9376-44BC-AE8F-77B6F20A0F5EQ34100447-9FD33196-3D8D-49D9-922F-AB0CB883499EQ34181825-76126F0E-B4C3-419C-AABA-C1534E5FC9C9Q34384552-F8407DAB-C696-4A6D-BC46-B6771E8F1DA0Q35085378-C9BED268-0256-4F98-9025-80ABC2918FA1Q35160248-EDF57AC4-6618-4D19-B4F4-24483B91CE99Q35236309-6EC2E0CC-AEA9-4187-A0CB-DDAD672A56DCQ35662050-871A1A82-FEF8-45EA-9810-A228721B127FQ36077310-9FC8B2A1-45B8-4120-B82C-E8DB0C8DEC6EQ36115552-92CF191F-C9A8-4346-B7C3-6A1F291C9F99Q36159356-276CC6C5-E337-4C30-BF5E-28251EA923C2Q36261418-5C22D46F-EB17-4465-9507-446891377B1DQ36446704-1683C110-E831-4808-AE6B-9579CC586307Q36606190-B410FAB7-D775-4DA5-999A-D799ECEE388BQ37089567-853F4F35-2078-4306-AF72-A1C561540347Q37195327-193F515F-9978-4C3E-8839-31CB0429C60CQ37195332-2CF4766A-B45C-441F-9486-6B8F26EA7969Q37351178-DC4C8D2C-0C0E-4D3C-BA26-A99B2A57B9C6Q37394309-8C4CDF33-A2B9-4B16-B20E-0C6CABE81C20Q37409451-3C46E349-FE8D-4393-BC79-1D8E3F9D4C81Q37486207-62A4CA1E-366A-4BC6-BCBE-827108A97EDDQ37599875-AA70677E-C550-4433-BF00-199FA893AA58Q37732309-D5DDF6B9-061B-49E9-A2FD-A38D4F630E43Q37791156-C62BF85D-54EE-4208-BBD5-B5F9521488A8Q38166695-9ECC6EA0-CB97-4D0D-BC89-9B7BEB9A74F8Q38391250-BC677AEA-74E8-44FF-B377-F3D914A92C76Q38764529-CF99793D-D245-43DC-8B13-0D2591A5FB17Q38767602-BF93F40C-22E5-42F5-B229-9227A9DF0D4AQ38967657-2B123BC7-79C7-4DA7-95B6-E1E4AB48208EQ42923084-C60E307D-4222-43FB-B050-E703EA1B1E5BQ42958735-E16960D8-CBA0-4D44-965C-142F42C3B39BQ43151256-9827B88D-C1ED-4033-ADCB-89EC39D6CB4BQ44877055-44EC976D-20AB-4389-BFAA-18D3541D72EDQ44906190-CB8DC491-CBCA-4D76-9DDB-6CC6D36453E5Q46746745-514C9B2B-47D9-4CAD-B37F-07F34F70BBBE
P2860
Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Evaluation of platelet activat ...... ine or nortriptyline treatment
@ast
Evaluation of platelet activat ...... ine or nortriptyline treatment
@en
Evaluation of platelet activat ...... ine or nortriptyline treatment
@nl
type
label
Evaluation of platelet activat ...... ine or nortriptyline treatment
@ast
Evaluation of platelet activat ...... ine or nortriptyline treatment
@en
Evaluation of platelet activat ...... ine or nortriptyline treatment
@nl
prefLabel
Evaluation of platelet activat ...... ine or nortriptyline treatment
@ast
Evaluation of platelet activat ...... ine or nortriptyline treatment
@en
Evaluation of platelet activat ...... ine or nortriptyline treatment
@nl
P2093
P3181
P1476
Evaluation of platelet activat ...... ine or nortriptyline treatment
@en
P2093
B G Pollock
F Laghrissi-Thode
W R Wagner
P304
P3181
P356
10.1097/00004714-200004000-00004
P407
P577
2000-04-01T00:00:00Z